All In MedTech

Device Trial Radar · NCT07086742

Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate

Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

53

Actual

Start

Jul 20, 2025

Primary completion

Nov 23, 2025

Study completion Nov 23, 2025

Sponsor

Lead sponsor
Pathway Medtech, LLC.Not on our public-company list
Sponsor type
Industry
Collaborators
Haku Technology
First posted
Jul 25, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical study is to investigate a new medical device, the Smart Mask V1 System (herein 'Smart Mask'), and particularly its measurements of blood oxygen levels (SpO2) and pulse rate (PR) in healthy adults aged 18 to 65. More specifically, the study is directed at answering the following questions: * Can the Smart Mask accurately measure SpO2 levels compared to established reference devices (reference oximeters, blood gas) throughout the range of SpO2 \~ 70 - 100%? * Can the Smart Mask accurately measure PR during the same conditions? * Does skin pigmentation impact the accuracy of Smart Mask's measurements of SpO2 and PR. The following reference devices will be used in the study: * An FDA-cleared fingertip pulse oximeter (Nellcor Portable SpO2 Patient Monitoring System, PM10N) * A laboratory-grade CO-oximeter (Radiometer ABL90 FLEX) that analyzes oxygen saturation from blood samples. Study participants will: * Wear the Smart Mask on their face and a fingertip pulse oximeter while lying down * Breathe air with gradually reduced oxygen levels inside a specialized hypoxia room while being closely. * In a second phase of the study, have a catheter inserted into a wrist artery for blood sampling to directly measure oxygen levels with the CO-oximeter.

Conditions

  • Sleep-disordered Breathing (SDB)
  • Sleep Apnea
  • Sleep Quality

Interventions

  • Smart Mask V1 SystemDevice

    PPG-based sensors integrated into a PAP-compatible face mask to measure SpO2 and PR.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SpO2 Accuracy (Arms)Time frame: During each hypoxia session (90-140 minutes)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Complementair Medisch Centrum (CMC) Europe

    Genk, Belgium

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.